Applied dna to present at the h.c. wainwright 24th annual global investment conference september 12-14, 2022

Stony brook, n.y.--(business wire)---- $apdn #lineardna--applied dna sciences, inc. (nasdaq: apdn) (“applied dna” or the “company”), a leader in pcr-based dna technologies, today announced it will be featured as a presenting company at the h.c. wainwright 24th annual global investment conference on september 13, 2022, at 2:00 pm eastern time. the conference is being held as a hybrid in-person/virtual event from september 12 to 14, 2022. applied dna's ceo and chairman of the board of directors, dr. james a. hayward,
APDN Ratings Summary
APDN Quant Ranking